Critical Drug Interactions — What Every Veteran Should Know
Cannabis interacts clinically with many VA-prescribed medications. This is one of the most under-recognized risks for veterans — especially older veterans on multiple prescriptions. The interactions are real, the mechanisms are well-characterized, and in at least one case (warfarin) the clinical consequences can be severe.
Warfarin Warning
How Cannabis Interacts With Medications
Cannabis interactions occur through two main mechanisms:
- Cytochrome P450 (CYP450) enzyme inhibition: THC, CBD, and minor cannabinoids inhibit several CYP450 enzymes that metabolize prescription drugs. The result is that drug levels rise above therapeutic ranges, increasing side effects and toxicity risk.
- Pharmacodynamic interactions: Cannabis and many prescription drugs have overlapping effects (sedation, CNS depression, blood pressure changes). Combining them produces additive effects without any enzyme interaction.
CBD is actually a more potent CYP450 inhibitor than THC for several enzymes. Products marketed as "just CBD" or "THC-free" are not automatically safe — they may produce significant drug interactions even without psychoactivity.
Warfarin / Coumadin — Clinically Significant
Mechanism: THC, CBD, and CBN inhibit CYP2C9 with IC50 values of 2.29–4.81 μmol/L. CYP2C9 metabolizes warfarin. Inhibition produces warfarin accumulation and INR elevation.
Clinical findings:
- Systematic review found INR elevated in 6 of 7 cases
- INR increases up to +9.61
- Warfarin dose reductions of 22–31% typically required
- Case reports document INR >10 with bleeding requiring hospitalization
Action: Any veteran on warfarin who uses (or starts using) cannabis must:
- Inform their VA provider and anticoagulation clinic immediately
- Have INR monitored more frequently (weekly or biweekly until stable)
- Expect possible warfarin dose adjustment
- Watch for bleeding signs: unusual bruising, nosebleeds, blood in urine/stool, prolonged bleeding from cuts
- Seek emergency care for any significant bleeding or head trauma
SSRIs / SNRIs (Sertraline, Fluoxetine, Venlafaxine)
Mechanism: CBD inhibits CYP2D6 (fluoxetine metabolism) and CYP2C19 (sertraline metabolism). THC has less effect on these enzymes. Combined cannabis-SSRI use can increase SSRI levels modestly.
Clinical significance: Usually mild, but may produce increased SSRI side effects: nausea, drowsiness, sexual dysfunction, and in rare cases serotonin syndrome at very high CBD doses. Serotonin syndrome symptoms include agitation, confusion, rapid heart rate, dilated pupils, muscle rigidity, and high fever — seek emergency care if these develop.
Action: Inform your VA provider. Dose adjustment is rarely needed for typical cannabis use, but symptoms should be monitored.
Benzodiazepines (Alprazolam, Clonazepam, Diazepam, Lorazepam)
Mechanism: Additive CNS depression produces enhanced sedation and impaired coordination. CBD also inhibits CYP3A4, potentially increasing benzodiazepine blood levels.
Clinical significance: Combined use increases fall risk, particularly in older veterans. Enhanced sedation can impair driving, work performance, and daily functioning. Cognitive impairment is additive.
Action: Avoid combining if possible. If unavoidable, use lowest effective doses of both, avoid driving, and discuss with your VA provider. Veterans with benzodiazepine prescriptions should be especially cautious starting cannabis for the first time.
Opioids (Oxycodone, Hydrocodone, Morphine, Buprenorphine, Methadone)
Mechanism: Additive sedation. Theoretical respiratory depression risk, though clinical reports of cannabis-opioid respiratory depression are rare. Pharmacokinetic interactions through CYP450 are minor for most opioids.
Clinical significance: The primary risk is enhanced sedation rather than respiratory depression. Some observational evidence suggests cannabis may allow supervised opioid dose reduction (see chronic pain page), but this should only occur under medical supervision. Unsupervised opioid dose reduction in the context of cannabis use can produce withdrawal symptoms that may be misattributed to cannabis effects.
Action: If you are on chronic opioid therapy and considering cannabis, discuss with your VA pain team. Never reduce opioid doses on your own based on cannabis use.
Antipsychotics (Quetiapine, Risperidone, Olanzapine, Aripiprazole)
Mechanism: CBD inhibits CYP2D6 and CYP3A4, potentially increasing blood levels of both medications. Cannabis also has its own effects on dopamine signaling, which may interact with antipsychotic mechanisms.
Clinical significance: Enhanced sedation, metabolic effects (weight gain, glucose), and orthostatic hypotension risk. Theoretically, high-dose THC could destabilize psychiatric symptoms in veterans with comorbid schizophrenia spectrum disorders — avoid in these populations.
Action: Discuss with VA mental health. Particular caution for veterans with any psychotic disorder history.
Blood Pressure Medications
Mechanism: Cannabis can cause acute blood pressure changes — typically an initial increase followed by a decrease. Combined with antihypertensives, the result is often orthostatic hypotension. CBD may inhibit CYP3A4 metabolism of some calcium channel blockers (amlodipine, verapamil, diltiazem), increasing their levels.
Clinical significance: Orthostatic hypotension is the primary concern, increasing fall risk. Dizziness upon standing is a warning sign. Older veterans, veterans on multiple blood pressure medications, and veterans with diabetes or autonomic neuropathy face the highest risk.
Action: Monitor blood pressure when starting cannabis. Rise slowly from seated or lying positions for the first weeks. Discuss with VA primary care if dizziness develops.
Immunosuppressants (Tacrolimus, Cyclosporine, Sirolimus)
Mechanism: CBD strongly inhibits CYP3A4, which metabolizes these transplant drugs. Cannabis use can significantly elevate their blood levels.
Clinical significance: Veterans who have had organ transplants and use tacrolimus or cyclosporine can develop drug toxicity (kidney damage, neurotoxicity) if they start cannabis without coordinated monitoring. Avoid cannabis if you are on these medications without transplant team involvement.
Seizure Medications (Clobazam, Valproate)
Mechanism: CBD can significantly increase clobazam levels via CYP2C19 inhibition, and can increase valproate-related liver enzyme elevation.
Clinical significance: For veterans on anticonvulsants — including some TBI patients — CBD products can produce drug interactions severe enough to require dose adjustment or monitoring. These interactions are documented from the Epidiolex clinical trials, so they apply to any CBD source, not just the FDA-approved product.
Summary Table
| Medication Class | Interaction Severity | Key Concern |
|---|---|---|
| Warfarin | High | INR elevation, bleeding risk |
| Tacrolimus / Cyclosporine | High | Drug toxicity |
| Clobazam | High (for CBD) | Elevated clobazam levels |
| Benzodiazepines | Moderate | Additive sedation, fall risk |
| Opioids | Moderate | Additive sedation |
| Antipsychotics | Moderate | Sedation, orthostasis, psychiatric destabilization |
| Blood pressure meds | Moderate | Orthostatic hypotension, fall risk |
| SSRIs / SNRIs | Low-Moderate | Increased side effects |
| Statins | Low-Moderate | Possible muscle toxicity via CYP3A4 |
| Diabetes medications | Low | Appetite stimulation, unpredictable glucose |
The Bottom Line for Veterans
- Tell your VA provider if you use or are starting cannabis. Confidentiality is protected under 38 U.S.C. § 7332.
- Bring your full medication list when discussing cannabis — including over-the-counter supplements
- If you are on warfarin, talk to your provider before any cannabis use
- CBD is not automatically safe. It is actually a more potent CYP450 inhibitor than THC for several enzymes.
- Start low and go slow — see Start Low, Go Slow
- Watch for new symptoms: unusual bleeding, dizziness, excessive sedation, confusion — these can signal interaction-related problems